PRHSX vs. FBTTX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. FBTTX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
PRHSX vs. FBTTX - Performance Comparison
Loading graphics...
Returns By Period
In the year-to-date period, PRHSX achieves a -5.57% return, which is significantly lower than FBTTX's 2.00% return. Both investments have delivered pretty close results over the past 10 years, with PRHSX having a 11.80% annualized return and FBTTX not far behind at 11.38%.
PRHSX
- 1D
- -0.16%
- 1M
- -1.85%
- YTD
- -5.57%
- 6M
- 19.35%
- 1Y
- 36.53%
- 3Y*
- 10.42%
- 5Y*
- 5.67%
- 10Y*
- 11.80%
FBTTX
- 1D
- -0.32%
- 1M
- 0.79%
- YTD
- 2.00%
- 6M
- 14.67%
- 1Y
- 65.63%
- 3Y*
- 20.25%
- 5Y*
- 8.60%
- 10Y*
- 11.38%
PRHSX vs. FBTTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | -5.57% | 33.71% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 2.00% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
Correlation
The correlation between PRHSX and FBTTX is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification — they'll tend to fall together during downturns. For meaningful risk reduction, look for holdings with correlations below 0.5.
PRHSX vs. FBTTX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is lower than FBTTX's 1.28% expense ratio.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRHSX vs. FBTTX — Risk / Return Rank
PRHSX
FBTTX
PRHSX vs. FBTTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRHSX | FBTTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.20 | 2.03 | -0.82 |
Sortino ratioReturn per unit of downside risk | 2.04 | 2.64 | -0.60 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.34 | -0.08 |
Calmar ratioReturn relative to maximum drawdown | 2.25 | 4.03 | -1.79 |
Martin ratioReturn relative to average drawdown | 6.77 | 15.45 | -8.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PRHSX | FBTTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.20 | 2.03 | -0.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | 0.37 | -0.06 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.60 | 0.46 | +0.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.64 | 0.30 | +0.34 |
Drawdowns
PRHSX vs. FBTTX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -42.96%, smaller than the maximum FBTTX drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for PRHSX and FBTTX.
Loading graphics...
Drawdown Indicators
| PRHSX | FBTTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.96% | -63.75% | +20.79% |
Max Drawdown (1Y)Largest decline over 1 year | -12.81% | -8.61% | -4.20% |
Max Drawdown (5Y)Largest decline over 5 years | -27.61% | -36.64% | +9.03% |
Max Drawdown (10Y)Largest decline over 10 years | -28.97% | -39.04% | +10.07% |
Current DrawdownCurrent decline from peak | -8.53% | -2.78% | -5.75% |
Average DrawdownAverage peak-to-trough decline | -8.75% | -21.95% | +13.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.25% | 3.54% | +0.71% |
Volatility
PRHSX vs. FBTTX - Volatility Comparison
The current volatility for T. Rowe Price Health Sciences Fund (PRHSX) is 6.58%, while Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a volatility of 8.90%. This indicates that PRHSX experiences smaller price fluctuations and is considered to be less risky than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PRHSX | FBTTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.58% | 8.90% | -2.32% |
Volatility (6M)Calculated over the trailing 6-month period | 16.20% | 16.93% | -0.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.51% | 25.62% | -3.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.07% | 23.30% | -5.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.68% | 24.57% | -4.89% |
Dividends
PRHSX vs. FBTTX - Dividend Comparison
PRHSX's dividend yield for the trailing twelve months is around 25.47%, more than FBTTX's 1.50% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 25.47% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.50% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |